ID   RB6I2_RAT               Reviewed;         948 AA.
AC   Q811U3; Q8CIY9;
DT   31-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2003, sequence version 1.
DT   02-OCT-2024, entry version 140.
DE   RecName: Full=ELKS/Rab6-interacting/CAST family member 1;
DE            Short=ERC-1;
DE   AltName: Full=CAZ-associated structural protein 2;
DE            Short=CAST2;
DE   AltName: Full=Rab6-interacting protein 2;
GN   Name=Erc1; Synonyms=Cast2, Elks, Rab6ip2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND INTERACTION WITH RIMS1 AND CAST1.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=14723704; DOI=10.1111/j.1356-9597.2004.00697.x;
RA   Deguchi-Tawarada M., Inoue E., Takao-Rikitsu E., Inoue M., Ohtsuka T.,
RA   Takai Y.;
RT   "CAST2: identification and characterization of a protein structurally
RT   related to the presynaptic cytomatrix protein CAST.";
RL   Genes Cells 9:15-23(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], ALTERNATIVE SPLICING, TISSUE SPECIFICITY,
RP   SUBCELLULAR LOCATION, INTERACTION WITH RIMS1 AND RIMS2, AND MUTAGENESIS OF
RP   GLU-943; GLU-944; GLY-945; ILE-946; TRP-947 AND ALA-948.
RX   PubMed=12391317; DOI=10.1073/pnas.182532999;
RA   Wang Y., Liu X., Biederer T., Suedhof T.C.;
RT   "A family of RIM-binding proteins regulated by alternative splicing:
RT   Implications for the genesis of synaptic active zones.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:14464-14469(2002).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-937, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [4]
RP   STRUCTURE BY NMR OF 939-948 IN COMPLEX WITH RIMS1, AND INTERACTION WITH
RP   RIMS1.
RX   PubMed=16095618; DOI=10.1016/j.jmb.2005.07.047;
RA   Lu J., Li H., Wang Y., Sudhof T.C., Rizo J.;
RT   "Solution structure of the RIM1alpha PDZ domain in complex with an ELKS1b
RT   C-terminal peptide.";
RL   J. Mol. Biol. 352:455-466(2005).
CC   -!- FUNCTION: Regulatory subunit of the IKK complex. Probably recruits
CC       IkappaBalpha/NFKBIA to the complex (By similarity). May be involved in
CC       the organization of the cytomatrix at the nerve terminals active zone
CC       (CAZ) which regulates neurotransmitter release. May be involved in
CC       vesicle trafficking at the CAZ. May be involved in Rab-6 regulated
CC       endosomes to Golgi transport. {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with the GTB-bound forms of RAB6A isoform 1 and
CC       isoform 2 and with RAB6B. The interaction was strongest with RAB6B,
CC       followed by RAB6A isoform 2 and weakest with RAB6A isoform 1 (By
CC       similarity). Part of a complex with CHUK, IKBKB and IKBKG. Interacts
CC       with CHUK, IKBKB and IKBKG. The interaction with IKBKG is independent
CC       of CHUK and IKBKB. Interacts with NFKBIA (By similarity). Isoform 1
CC       interacts through its C-terminus with the PDZ domains of RIMS1 and
CC       RIMS2. Interacts with ERC2/CAST1. Interacts with SDCCAG8. Part of a
CC       cortical microtubule stabilization complex (CMSC) composed of KANK1,
CC       PPFIA1, PPFIBP1, ERC1/ELKS, PHLDB2/LL5beta, CLASPs, KIF21A and possibly
CC       additional interactors; within CMSCs KANK1 and PHLDB2/LL5beta appear to
CC       be the core components for targeting of microtubule-binding proteins
CC       KIF21A and CLASPs, whereas PPFIA1, PPFIBP1 and ERC1/ELKS serve as
CC       scaffolds for protein clustering. {ECO:0000250,
CC       ECO:0000250|UniProtKB:Q8IUD2, ECO:0000269|PubMed:12391317,
CC       ECO:0000269|PubMed:14723704, ECO:0000269|PubMed:16095618}.
CC   -!- INTERACTION:
CC       Q811U3; Q9JIR4: Rims1; NbExp=8; IntAct=EBI-3507502, EBI-3507436;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, microtubule organizing
CC       center, centrosome {ECO:0000250|UniProtKB:Q8IUD2}. Cytoplasm
CC       {ECO:0000269|PubMed:12391317}. Membrane {ECO:0000250}; Peripheral
CC       membrane protein {ECO:0000250}. Golgi apparatus membrane {ECO:0000250};
CC       Peripheral membrane protein {ECO:0000250}. Presynaptic active zone
CC       {ECO:0000269|PubMed:12391317}. Cell projection, podosome
CC       {ECO:0000250|UniProtKB:Q99MI1}. Note=Recruited on Golgi membranes by
CC       RAB6A in a GTP-dependent manner. Localized to the cortex of myotube
CC       podosomes (By similarity). {ECO:0000250, ECO:0000250|UniProtKB:Q99MI1}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=1;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1; Synonyms=CAST2a, ERC1b;
CC         IsoId=Q811U3-1; Sequence=Displayed;
CC   -!- TISSUE SPECIFICITY: Isoform 1 is specifically expressed in brain. A
CC       further probable isoform is widely expressed outside of brain It is
CC       referred to as ERC1a by PubMed:12391317 and characterized by a C-
CC       terminus identical to that of isoforms 1 in human and mouse.
CC       {ECO:0000269|PubMed:12391317}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY174115; AAO25554.1; -; mRNA.
DR   EMBL; AF541926; AAN39293.1; -; mRNA.
DR   RefSeq; NP_740769.2; NM_170788.2.
DR   PDB; 1ZUB; NMR; -; B=939-948.
DR   PDB; 8IJ9; X-ray; 2.04 A; C/D=849-922.
DR   PDBsum; 1ZUB; -.
DR   PDBsum; 8IJ9; -.
DR   AlphaFoldDB; Q811U3; -.
DR   SMR; Q811U3; -.
DR   BioGRID; 251829; 1.
DR   ELM; Q811U3; -.
DR   IntAct; Q811U3; 3.
DR   MINT; Q811U3; -.
DR   STRING; 10116.ENSRNOP00000070778; -.
DR   GlyGen; Q811U3; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q811U3; -.
DR   PhosphoSitePlus; Q811U3; -.
DR   PaxDb; 10116-ENSRNOP00000012397; -.
DR   UCSC; RGD:628733; rat. [Q811U3-1]
DR   AGR; RGD:628733; -.
DR   RGD; 628733; Erc1.
DR   eggNOG; KOG4809; Eukaryota.
DR   InParanoid; Q811U3; -.
DR   OrthoDB; 2880381at2759; -.
DR   EvolutionaryTrace; Q811U3; -.
DR   PRO; PR:Q811U3; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005813; C:centrosome; ISO:RGD.
DR   GO; GO:0036064; C:ciliary basal body; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0048788; C:cytoskeleton of presynaptic active zone; IBA:GO_Central.
DR   GO; GO:0098982; C:GABA-ergic synapse; ISO:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; ISO:RGD.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0008385; C:IkappaB kinase complex; ISO:RGD.
DR   GO; GO:0016020; C:membrane; IDA:ARUK-UCL.
DR   GO; GO:0002102; C:podosome; ISS:UniProtKB.
DR   GO; GO:0014069; C:postsynaptic density; IDA:ARUK-UCL.
DR   GO; GO:0098831; C:presynaptic active zone cytoplasmic component; IDA:SynGO.
DR   GO; GO:0099523; C:presynaptic cytosol; ISO:RGD.
DR   GO; GO:0045202; C:synapse; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0008021; C:synaptic vesicle; IDA:ARUK-UCL.
DR   GO; GO:0030165; F:PDZ domain binding; IDA:RGD.
DR   GO; GO:0031267; F:small GTPase binding; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0098882; F:structural constituent of presynaptic active zone; ISO:RGD.
DR   GO; GO:0048790; P:maintenance of presynaptic active zone structure; IBA:GO_Central.
DR   GO; GO:0007274; P:neuromuscular synaptic transmission; IBA:GO_Central.
DR   GO; GO:0015031; P:protein transport; IEA:UniProtKB-KW.
DR   GO; GO:0150037; P:regulation of calcium-dependent activation of synaptic vesicle fusion; ISO:RGD.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0099509; P:regulation of presynaptic cytosolic calcium ion concentration; ISO:RGD.
DR   GO; GO:0048167; P:regulation of synaptic plasticity; IBA:GO_Central.
DR   GO; GO:0042147; P:retrograde transport, endosome to Golgi; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0016082; P:synaptic vesicle priming; ISO:RGD.
DR   Gene3D; 1.10.287.1490; -; 1.
DR   InterPro; IPR019323; ELKS/CAST.
DR   PANTHER; PTHR18861; ELKS/RAB6-INTERACTING/CAST PROTEIN; 1.
DR   PANTHER; PTHR18861:SF1; ELKS_RAB6-INTERACTING_CAST FAMILY MEMBER 1; 1.
DR   Pfam; PF10174; Cast; 1.
DR   SUPFAM; SSF57997; Tropomyosin; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cell junction;
KW   Cell projection; Coiled coil; Cytoplasm; Cytoskeleton; Golgi apparatus;
KW   Membrane; Phosphoprotein; Protein transport; Reference proteome; Synapse;
KW   Transport.
FT   CHAIN           1..948
FT                   /note="ELKS/Rab6-interacting/CAST family member 1"
FT                   /id="PRO_0000097178"
FT   REGION          1..54
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          773..801
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          903..948
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          144..920
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        31..54
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        773..798
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        915..942
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         10
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99MI1"
FT   MOD_RES         17
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8IUD2"
FT   MOD_RES         21
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8IUD2"
FT   MOD_RES         37
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8IUD2"
FT   MOD_RES         38
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8IUD2"
FT   MOD_RES         55
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99MI1"
FT   MOD_RES         75
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8IUD2"
FT   MOD_RES         94
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8IUD2"
FT   MOD_RES         796
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99MI1"
FT   MOD_RES         937
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MUTAGEN         943
FT                   /note="E->K,A: No effect on RIMS1 and RIMS2 binding."
FT                   /evidence="ECO:0000269|PubMed:12391317"
FT   MUTAGEN         944
FT                   /note="E->K,A: No effect on RIMS1 and RIMS2 binding."
FT                   /evidence="ECO:0000269|PubMed:12391317"
FT   MUTAGEN         945
FT                   /note="G->D,A: Abolishes RIMS1 and RIMS2 binding."
FT                   /evidence="ECO:0000269|PubMed:12391317"
FT   MUTAGEN         946
FT                   /note="I->D,A: Abolishes RIMS1 and RIMS2 binding."
FT                   /evidence="ECO:0000269|PubMed:12391317"
FT   MUTAGEN         947
FT                   /note="W->D,A: Abolishes RIMS1 and RIMS2 binding."
FT                   /evidence="ECO:0000269|PubMed:12391317"
FT   MUTAGEN         948
FT                   /note="A->D: Abolishes RIMS1 and RIMS2 binding."
FT                   /evidence="ECO:0000269|PubMed:12391317"
FT   MUTAGEN         948
FT                   /note="A->L: Weakens RIMS1 and abolishes RIMS2 binding."
FT                   /evidence="ECO:0000269|PubMed:12391317"
FT   CONFLICT        771
FT                   /note="N -> S (in Ref. 2; AAN39293)"
FT                   /evidence="ECO:0000305"
FT   HELIX           850..879
FT                   /evidence="ECO:0007829|PDB:8IJ9"
FT   HELIX           884..915
FT                   /evidence="ECO:0007829|PDB:8IJ9"
SQ   SEQUENCE   948 AA;  108818 MW;  7CC15D7B1939561C CRC64;
     MYGSARSVGK VEPSSQSPGR SPRLPRSPRL GHRRTNSTGG SSGNSVGGGS GKTLSMENIQ
     SLNAAYATSG PMYLSDHENV GAETPKSTMT LGRSGGRLPY GVRMTAMGSS PNIASSGVAS
     DTIAFGEHHL PPVSMASTVP HSLRQARDNT IMDLQTQLKE VLRENDLLRK DVEVKESKLS
     SSMNSIKTFW SPELKKERAL RKDEASKITI WKEQYRVVQE ENQHMQMTIQ ALQDELRIQR
     DLNQLFQQDS SSRTGEPCVA ELTEENFQRL HAEHERQAKE LFLLRKTLEE MELRIETQKQ
     TLNARDESIK KLLEMLQSKG LSAKATEEDH ERTRRLAEAE MHVHHLESLL EQKEKENNML
     REEMHRRFEN APDSAKTKAL QTVIEMKDSK ISSMERGLRD LEEEIQMLKS NGALSTEERE
     EEMKQMEVYR SHSKFMKNKI GQVKQELSRK DTELLALQTK LETLTNQFSD SKQHIEVLKE
     SLTAKEQRAA ILQTEVDALR LRLEEKETML NKKTKQIQDM AEEKGTQAGE IHDLKDMLDV
     KERKVNVLQK KIENLQEQLR DKEKQMSSLK ERVKSLQADT TNTDTALTTL EEALADKERT
     IERLKEQRDR DEREKQEEID TYKKDLKDLK EKVSLLQGDL SEKEASLLDL KEHASSLASS
     GLKKDSRLKT LEIALEQKKE ECLKMESQLK KAHEATLEAR ASPEMSDRIQ QLEREIARYK
     DESSKAQTEV DRLLEILKEV ENEKNDKDKK IAELESLTSR QVKDQNKKVA NLKHKEQVEK
     KKSAQMLEEA RRREDSLSDS SQQLQVEELL MAMEKVKQEL ESMKAKLSST QQSLAEKETH
     LTNLRAERRK HLEEVLEMKQ EALLAAISEK DANIALLELS SSKKKTQEEV AALKREKDRL
     VQQLKQQTQN RMKLMADNYE DDHFRSSRSN QTNHKPSPDQ DEEEGIWA
//
